AU3863699A - Treatment of osteoporosis with leptin - Google Patents

Treatment of osteoporosis with leptin

Info

Publication number
AU3863699A
AU3863699A AU38636/99A AU3863699A AU3863699A AU 3863699 A AU3863699 A AU 3863699A AU 38636/99 A AU38636/99 A AU 38636/99A AU 3863699 A AU3863699 A AU 3863699A AU 3863699 A AU3863699 A AU 3863699A
Authority
AU
Australia
Prior art keywords
leptin
osteoporosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38636/99A
Inventor
Bartolome Burguera
B. Lawrence Riggs
Thierry Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Publication of AU3863699A publication Critical patent/AU3863699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
AU38636/99A 1998-04-20 1999-04-20 Treatment of osteoporosis with leptin Abandoned AU3863699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8232098P 1998-04-20 1998-04-20
US60082320 1998-04-20
PCT/US1999/008604 WO1999053939A1 (en) 1998-04-20 1999-04-20 Treatment of osteoporosis with leptin

Publications (1)

Publication Number Publication Date
AU3863699A true AU3863699A (en) 1999-11-08

Family

ID=22170469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38636/99A Abandoned AU3863699A (en) 1998-04-20 1999-04-20 Treatment of osteoporosis with leptin

Country Status (2)

Country Link
AU (1) AU3863699A (en)
WO (1) WO1999053939A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950417A3 (en) * 1998-02-23 2000-02-23 Pfizer Products Inc. Treatment of skeletal disorders
CA2376933A1 (en) * 1999-06-11 2000-12-21 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of leptin activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217327T3 (en) * 1995-11-22 2004-11-01 Amgen Inc., PROTEIN OB TO INCREASE THE MAGRO FABRIC MASS.
WO1997032022A2 (en) * 1996-03-01 1997-09-04 Amgen Inc. Canine ob protein compositions and methods
CA2251808A1 (en) * 1996-04-19 1997-10-30 Zymogenetics, Inc. Methods for inducing bone formation
WO1998018486A1 (en) * 1996-10-25 1998-05-07 Icogen Corporation Use of leptin to stimulate hematopoiesis

Also Published As

Publication number Publication date
WO1999053939A9 (en) 2000-05-25
WO1999053939A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
AU1345700A (en) Method of sterilizing females
AU2212299A (en) Compositions and methods for the treatment of tumor
AU1129600A (en) Multi-functional coatings for medical devices
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU3891299A (en) Combination therapy for treatment of depression
AU5849898A (en) Anaesthetic bone cement
AU1772399A (en) Well treatment
AU3596199A (en) Treatment of celiac disease
AU3784999A (en) Methods for treatment of pain
AU2740899A (en) Treatment of liquids
AU7715300A (en) Method of preventing osteoporosis
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU2333099A (en) Aryloxyanilides and related compounds
AU5342099A (en) Dental treatment methods
AU3863699A (en) Treatment of osteoporosis with leptin
AU2227999A (en) Human ependymin
AUPP375198A0 (en) An anticorrosion treatment
AU7545998A (en) Treatment of osteoporosis
AUPP229598A0 (en) Treatment of sunburn
AU6112299A (en) Treatment of effluents
AU2202100A (en) Human brainiac-5
AU2453399A (en) Bone cancer therapy
AU5524399A (en) Inorgasmia treatment
AU6088099A (en) Water treatment
AU5318399A (en) Acne treatment compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase